Abstract:Introduction: Mannose, a major monosaccharide component of N-glycans, involves in the glycometabolism of human body. Recently, mannose has been shown to suppress tumor growth through enhancing chemosensitivity and reducing the activity of mannose phosphate isomerase (MPH. However, it is largely unknown whether mannose exerts effects on nonsmall cell lung cancer (NSCLC). Materials and Methods: First, a mannose IC50 assay was conducted to find a suitable concentration of mannose for cell experiments. Then, vitro studies including CCK-8 assay, scratch wound healing assay, and TUNEL assay were performed to evaluate the effects of mannose on A549 cells, and an animal model was established to evaluate the antitumoural effect of mannose on NSCLC in vivo. Finally, immunohistochemistry was done to detect the expression of MPI by Rabbit Anti-MPI. Results: In this study, a concentration of mannose, 15mM, was used to explore the suppressive effect of mannose on A549 cells. CCK-8 assay demonstrated that mannose significantly inhibited the proliferation of A549 cells and enhanced the anti-tumor efficacy of carboplatin. Wound healing assay showed that mannose inhibits the migration of A549 cells, and mannose-induced migration inhibition was more efficient in A549 cells treated with carboplatin. TUNEL assay demonstrated that mannose significantly enhanced the efficacy of carboplatin to promote apoptosis treated by mannose (15mM) or carboplatin. The results of animal experiments revealed that the size and weight of tumors derived from A549 cells treated with mannose were smaller than those derived from control cells, and cotreatment with mannose and carboplatin had most efficient inhibition on tumor growth. MPI expression detection showed that the expression level of MPI in the stage Tis (tumor in situ) was the highest, while the stage IV has the lowest. Discussion: Collectively, our findings suggest that mannose inhibited cell proliferation and migration, promoted cell apoptosis and enhanced the efficacy of carboplatin in lung adenocarcinoma. Preliminary results showed that mannose had less side effect on health. In the future, mannose may be a potential candidate drug for adjuvant therapy of lung adenocarcinoma.

D-mannose promotes the degradation of IDH2 through upregulation of RNF185 and suppresses breast cancer

D-mannose Targets PD-1 to Lysosomal Degradation and Enhances T Cell-Mediated Anti-Tumor Immunity

Mannose Metabolism Normalizes Gut Homeostasis by Blocking the TNF-α-mediated Proinflammatory Circuit.

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

Nicotinamide N-methyltransferase Enhances the Capacity of Tumorigenesis Associated with the Promotion of Cell Cycle Progression in Human Colorectal Cancer Cells.

D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC

D-mannose suppresses macrophage release of extracellular vesicles and ameliorates type 2 diabetes

Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism

D-mannose induces regulatory T cells and suppresses immunopathology

Isocitrate dehydrogenases 2-mediated dysfunctional metabolic reprogramming promotes intestinal cancer progression via regulating HIF-1A signaling pathway

Black Raspberries Attenuate Colonic Adenoma Development in ApcMin Mice: Relationship to Hypomethylation of Promoters and Gene Bodies

D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K/Akt/mTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease

Mannose: A Sweet Option in the Treatment of Cancer and Inflammation

Mannose Impairs Lung Adenocarcinoma Growth and Enhances the Sensitivity of A549 Cells to Carboplatin.

Dendrobium Officinale Polysaccharide Triggers Mitochondrial Disorder to Induce Colon Cancer Cell Death Via ROS-AMPK-autophagy Pathway.

D-Mannose Suppresses Oxidative Response and Blocks Phagocytosis in Experimental Neuroinflammation.

D-mannose Attenuates Bone Loss in Mice Via Treg Cell Proliferation and Gut Microbiota-Dependent Anti-Inflammatory Effects.

The Regulatory Mechanisms and Inhibitors of Isocitrate Dehydrogenase 1 in Cancer

DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity

NADP(+)-IDH Mutations Promote Hypersuccinylation That Impairs Mitochondria Respiration and Induces Apoptosis Resistance.